Dong-A Socio Holdings Co., Ltd. (000640.KS)
KRW 110000.0
(4.86%)
KRW 110000.0
(4.86%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 202.06 Billion KRW | 41.95% |
| 2022 | 142.35 Billion KRW | -33.3% |
| 2021 | 213.41 Billion KRW | -13.75% |
| 2020 | 247.42 Billion KRW | 52.98% |
| 2019 | 161.72 Billion KRW | 7.34% |
| 2018 | 150.67 Billion KRW | -12.13% |
| 2017 | 171.46 Billion KRW | 485.72% |
| 2016 | 29.27 Billion KRW | -26.3% |
| 2015 | 39.72 Billion KRW | -46.53% |
| 2014 | 74.29 Billion KRW | 18.1% |
| 2013 | 62.9 Billion KRW | -76.52% |
| 2012 | 267.93 Billion KRW | 294.76% |
| 2011 | 67.87 Billion KRW | -53.64% |
| 2010 | 146.38 Billion KRW | 141.08% |
| 2009 | 60.72 Billion KRW | -43.81% |
| 2008 | 108.06 Billion KRW | -1.99% |
| 2007 | 110.25 Billion KRW | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 209.89 Billion KRW | -5.23% |
| 2024 Q1 | 221.47 Billion KRW | 9.61% |
| 2023 FY | 202.06 Billion KRW | 41.95% |
| 2023 Q2 | 208.83 Billion KRW | 18.97% |
| 2023 Q1 | 175.53 Billion KRW | 23.31% |
| 2023 Q3 | 248.95 Billion KRW | 19.21% |
| 2023 Q4 | 202.06 Billion KRW | -18.84% |
| 2022 Q4 | 142.35 Billion KRW | -15.08% |
| 2022 FY | 142.35 Billion KRW | -33.3% |
| 2022 Q3 | 167.63 Billion KRW | -1.64% |
| 2022 Q2 | 170.42 Billion KRW | -28.3% |
| 2022 Q1 | 237.68 Billion KRW | 11.38% |
| 2021 Q4 | 213.41 Billion KRW | 12.47% |
| 2021 FY | 213.41 Billion KRW | -13.75% |
| 2021 Q3 | 189.75 Billion KRW | -2.87% |
| 2021 Q2 | 195.35 Billion KRW | -12.64% |
| 2021 Q1 | 223.61 Billion KRW | -9.62% |
| 2020 Q3 | 262.7 Billion KRW | -0.66% |
| 2020 Q1 | 195.09 Billion KRW | 20.63% |
| 2020 Q2 | 264.46 Billion KRW | 35.56% |
| 2020 Q4 | 247.42 Billion KRW | -5.82% |
| 2020 FY | 247.42 Billion KRW | 52.98% |
| 2019 Q3 | 136.17 Billion KRW | -13.35% |
| 2019 Q4 | 161.72 Billion KRW | 18.76% |
| 2019 Q2 | 157.16 Billion KRW | -17.94% |
| 2019 Q1 | 191.52 Billion KRW | 27.11% |
| 2019 FY | 161.72 Billion KRW | 7.34% |
| 2018 Q4 | 150.67 Billion KRW | 11.63% |
| 2018 FY | 150.67 Billion KRW | -12.13% |
| 2018 Q2 | 136.05 Billion KRW | -0.5% |
| 2018 Q1 | 136.74 Billion KRW | -20.25% |
| 2018 Q3 | 134.98 Billion KRW | -0.79% |
| 2017 Q4 | 171.46 Billion KRW | -1.34% |
| 2017 Q3 | 173.79 Billion KRW | -3.32% |
| 2017 Q2 | 179.75 Billion KRW | 1.45% |
| 2017 FY | 171.46 Billion KRW | 485.72% |
| 2017 Q1 | 177.19 Billion KRW | 505.27% |
| 2016 FY | 29.27 Billion KRW | -26.3% |
| 2016 Q2 | 33.57 Billion KRW | -31.59% |
| 2016 Q3 | 32.92 Billion KRW | -1.93% |
| 2016 Q4 | 29.27 Billion KRW | -11.08% |
| 2016 Q1 | 49.07 Billion KRW | 23.54% |
| 2015 Q4 | 39.72 Billion KRW | 0.74% |
| 2015 Q3 | 39.43 Billion KRW | 2.07% |
| 2015 FY | 39.72 Billion KRW | -46.53% |
| 2015 Q1 | 21.84 Billion KRW | -70.6% |
| 2015 Q2 | 38.63 Billion KRW | 76.84% |
| 2014 Q3 | 53.72 Billion KRW | -24.5% |
| 2014 FY | 74.29 Billion KRW | 18.1% |
| 2014 Q4 | 74.29 Billion KRW | 38.29% |
| 2014 Q2 | 71.15 Billion KRW | -36.63% |
| 2014 Q1 | 112.27 Billion KRW | 78.49% |
| 2013 Q2 | 65.45 Billion KRW | 125.24% |
| 2013 Q3 | 64.11 Billion KRW | -2.05% |
| 2013 FY | 62.9 Billion KRW | -76.52% |
| 2013 Q4 | 62.9 Billion KRW | -1.88% |
| 2013 Q1 | 29.06 Billion KRW | -89.15% |
| 2012 Q1 | 33.77 Billion KRW | 0.0% |
| 2012 Q4 | 267.93 Billion KRW | 0.0% |
| 2012 FY | 267.93 Billion KRW | 294.76% |
| 2011 Q2 | 134.48 Billion KRW | -6.39% |
| 2011 FY | 67.87 Billion KRW | -53.64% |
| 2011 Q1 | 143.66 Billion KRW | 0.0% |
| 2011 Q3 | 135.35 Billion KRW | 0.65% |
| 2010 Q3 | 170.09 Billion KRW | 0.47% |
| 2010 Q1 | 55.8 Billion KRW | 0.0% |
| 2010 Q2 | 169.29 Billion KRW | 203.37% |
| 2010 FY | 146.38 Billion KRW | 141.08% |
| 2009 Q1 | 102.73 Billion KRW | 0.0% |
| 2009 Q2 | 96.88 Billion KRW | -5.7% |
| 2009 FY | 60.72 Billion KRW | -43.81% |
| 2009 Q3 | 98.08 Billion KRW | 1.25% |
| 2008 Q3 | 96.45 Billion KRW | 1.2% |
| 2008 Q1 | 104.93 Billion KRW | 0.0% |
| 2008 Q2 | 95.31 Billion KRW | -9.18% |
| 2008 FY | 108.06 Billion KRW | -1.99% |
| 2007 Q1 | 40.83 Billion KRW | 0.0% |
| 2007 Q2 | 60.49 Billion KRW | 48.17% |
| 2007 Q3 | 122 Billion KRW | 101.66% |
| 2007 FY | 110.25 Billion KRW | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -1381.385% |
| Ildong Holdings Co., Ltd. | 29.87 Billion KRW | -576.32% |
| HANDOK Inc. | 123.78 Billion KRW | -63.242% |
| Kukje Pharma Co., Ltd. | 475.74 Million KRW | -42372.871% |
| Yuhan Corporation | 60.23 Billion KRW | -235.462% |
| Dong-A ST Co., Ltd. | 161.99 Billion KRW | -24.736% |
| SAMSUNG PHARM. Co., LTD. | 101.81 Million KRW | -198354.147% |
| Hanmi Pharm. Co., Ltd. | 82.02 Billion KRW | -146.331% |
| Hanall Biopharma Co.,Ltd | 590.3 Million KRW | -34129.795% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -3239.862% |
| Dong Sung Bio Pharm.Co.,Ltd. | 18.52 Billion KRW | -990.903% |
| MYUNGMOON Pharm co.,Ltd | 12.58 Billion KRW | -1505.677% |
| Hana Pharm Co., Ltd. | 1.59 Billion KRW | -12537.968% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -1381.385% |
| Ilsung Pharmaceuticals Co., Ltd. | 119.67 Million KRW | -168737.173% |
| REYON Pharmaceutical Co., Ltd. | 121 Billion KRW | -66.993% |
| Aprogen pharmaceuticals,Inc. | 32 Billion KRW | -531.443% |
| JW Holdings Corporation | 20.65 Billion KRW | -878.159% |
| Ildong Pharmaceutical Co., Ltd. | 14.82 Billion KRW | -1262.963% |
| Chong Kun Dang Pharmaceutical Corp. | 30 Billion KRW | -573.539% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -573.539% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -92182.017% |
| Hyundai Pharmaceutical Co., Ltd. | 580.64 Million KRW | -34699.445% |
| Samil Pharmaceutical Co.,Ltd | 49.56 Billion KRW | -307.642% |
| Jeil Pharmaceutical Co.,Ltd | 4.45 Billion KRW | -4438.666% |
| Yuyu Pharma, Inc. | 13.64 Billion KRW | -1381.385% |
| Kwang Dong Pharmaceutical Co., Ltd. | 19.02 Billion KRW | -961.936% |
| Daewoong pharmaceutical Co.,Ltd | 93.41 Billion KRW | -116.304% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -573.539% |
| Yuhan Corporation | 60.23 Billion KRW | -235.462% |
| Jeil Pharma Holdings Inc | 10.5 Billion KRW | -1824.396% |
| Yungjin Pharm. Co., Ltd. | 40.37 Billion KRW | -400.427% |
| Suheung Co., Ltd. | 74 Billion KRW | -173.03% |
| JW Pharmaceutical Corporation | 30 Billion KRW | -573.539% |
| Samjin Pharmaceuticals Co., Ltd. | 4.16 Billion KRW | -4749.51% |
| Korea United Pharm Inc. | 10.96 Billion KRW | -1743.208% |
| CKD Bio Corp. | 69.43 Billion KRW | -191.024% |
| Daewon Pharmaceutical Co., Ltd. | 34.57 Billion KRW | -484.419% |
| Dongwha Pharm.Co.,Ltd | 16.12 Billion KRW | -1152.887% |
| Whan In Pharm Co.,Ltd. | 307.05 Million KRW | -65706.069% |
| Shin Poong Pharm.Co.,Ltd. | 218.96 Million KRW | -92182.017% |
| Chong Kun Dang Holdings Corp. | 72.11 Billion KRW | -180.204% |
| Boryung Corporation | 151.7 Billion KRW | -33.191% |
| Bukwang Pharmaceutical Co., Ltd. | 78.52 Billion KRW | -157.321% |
| Ilyang Pharmaceutical Co.,Ltd | 6.05 Billion KRW | -3239.862% |
| JW Lifescience Corporation | 168 Million KRW | -120174.778% |